Mayne Pharma reported $745.75M in Equity Capital and Reserves for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Ansell ANN:AU $ 1.53B 17.7M
Cochlear COH:AU $ 1.73B 28.1M
CSL CSL:AU $ 14.03B 5.65B
Ecofibre Ltd EOF:AU 113.08M 1.29M
Healius Ltd HLS:AU $ 1.94B 80M
Integral Diagnostics Ltd IDX:AU 254.74M 1.34M
Nanosonics Ltd NAN:AU $ 140.14M 4.57M
Next Science Ltd NXS:AU 10.77M 5.3M
Polynovo Ltd PNV:AU 20.07M 2.28M
Probiotec Ltd PBP:AU 68.61M 2.15M
ResMed RMD:AU $ 3.15B 260.16M
Sigma Healthcare Ltd SIG:AU 503.27M 30.95M
Sonic Healthcare SHL:AU $ 7.05B 668.87M
Telix Pharmaceuticals Ltd TLX:AU 2.16M 45.77M